Asymchem Laboratories (Tianjin) Co., Ltd.

Research Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) on Bullrun: market cap CNY 53.97B, P/E 50.9, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker002821.SZ
ExchangeSZ
CountryChina
SectorHealthcare
IndustryBiotechnology
CurrencyCNY
Market capCNY 53.97B
P/E50.9
Dividend yield0.9%
Financial periodQ2 2026
RevenueCNY 1.80B
Net incomeCNY 216.14M
Free cash flow-CNY 211.75M
Gross margin41.5%

Valuation Snapshot

latest market cap is CNY 53.97B; P/E is 50.9; dividend yield is 0.9%.

Peer valuation comparison

Latest P/E is 50.89x versus a Healthcare sector median of 21.75x (134.0% above).

Latest dividend yield is 0.87% versus a Healthcare sector median of 2.4% (63.7% below).

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	CNY 53.97B	50.9	0.9%	1.3

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.3 CNY, yield 0.9%.

About Asymchem Laboratories (Tianjin) Co., Ltd.

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, including antibody-peptide conjugates; formulation CDMO; clinical CRO; synthetic biology and new technology output business.

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Hualan Biological Engineering INC (002007.SZ) Shanghai RAAS Blood Products Co Ltd (002252.SZ) Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) CANbridge Pharmaceuticals Inc. (1228.HK) 3D Medicines Inc. (1244.HK) Ocumension Therapeutics (1477.HK) 3SBio Inc. (1530.HK) LongBio Pharma (Suzhou) Co., Ltd. (1779.HK) Innovent Biologics, Inc. (1801.HK) Viva Biotech Holdings (1873.HK) BioDlink International Company Limited (1875.HK) Shanghai Junshi Biosciences Co., Ltd. (1877.HK)

Frequently asked questions

What is Asymchem Laboratories (Tianjin) Co., Ltd.'s market cap?

Asymchem Laboratories (Tianjin) Co., Ltd.'s market capitalization is CNY 53.97B.

What is Asymchem Laboratories (Tianjin) Co., Ltd.'s P/E ratio?

Asymchem Laboratories (Tianjin) Co., Ltd.'s price-to-earnings (P/E) ratio is 50.9.

Does Asymchem Laboratories (Tianjin) Co., Ltd. pay a dividend?

Asymchem Laboratories (Tianjin) Co., Ltd. has a dividend yield of 0.9%.